Kearns-Sayre Syndrome

Article

Patient is a 39 year old man with past medical history of Kearns-Sayre Syndrome diagnosed at 12 years of age that presented with complaints of exertional dyspnea and progressively decreasing exertional capacity.

Patient is a 39 year old man with past medical history of Kearns-Sayre Syndrome diagnosed at 12 years of age that presented with complaints of exertional dyspnea and progressively decreasing exertional capacity. 

An echocardiogram was performed which revealed globally depressed left ventricular systolic function. The patient was without risk factors for cadiomyopathy, and an extensive work-up, including cardiac catheterization, was performed without a causative etiology found. Kearns-Sayre Syndrome has rarely been associated with an idiopathic cardiomyopathy with diffuse and focal interstitial fibrosis primarily of the subendocardium found by histopathological examination . 

Cardiac magnetic resonance imaging was performed to evaluate for fibrosis and infiltrative disease. The patient was imaged in multiple tomographic planes utilizing dynamic, T1 and T2 dark blood, perfusion and delayed hyper-enhancement sequences.
         
 

A. Short axis view with T1 dark blood imaging

 

B. Long axis view with T1 dark blood imaging

 

C. Short axis view with delayed enhancement imaging

 

D. Long axis view with delayed enhancement imaging.

Findings

Contrast and non-contrast imaging revealed the previously noted severely depressed systolic function and biventricular dilatation without evidence of infiltrative disease or fibrosis.

Discussion

Kearns-Sayre Syndrome is a mitochondrial myopathy that is characterized by progressive ophthalmoplegia, retinal abnormalities, ptosis, and cardiac conduction defects. It is caused by a mitochondrial DNA rearrangement mutation. There have been rare cases associated with progressive cardiomyopathy for which endomyocardial biopsy has previously shown non-specific interstitial fibrosis primarily of the subendocardium.

Our study did not reveal magnetic resonance imaging evidence of the previously noted findings of interstitial fibrosis nor infiltrative disease in this patient with Kearns-Sayre syndrome associated cardiomyopathy.

Case by  David J. Ternes D.O., Mount Clemens Regional Medical Center, Mount Clemens, MI

References:
Channer KS, Cardiomyopathy in the Kearns-Sayre syndrome. Br Heart J 1988; 59: 486-90

Chinnery PF, Myocardial Disorders Overview. NCBI Bookshelf ID:  NBK1224 PMID: 20301403

Edelman RR, Contrast-enhanced MR imaging of the heart: overview of the literature. Radiology 2004; 232:653-68

Moon JC, Myocardial fibrosis in glycogen storage disease type III.  Circulation 2003; 107:e47
 

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.